12:00 AM
 | 
Mar 19, 2012
 |  BC Week In Review  |  Company News  |  Deals

Eclat Pharmaceuticals, Flamel deal

Eclat complements Flamel in U.S. product development and market analysis, according to Flamel. Eclat's only marketed product, Hycet hydrocodone bitartrate and acetaminophen, is indicated to treat moderate to moderately severe pain in patients two years of age...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >